The global gabapentin market was estimated to be worth USD 2.5 billion in 2022, and a compound annual growth rate (CAGR) of 2.6% is anticipated over the course of the projected period. The market is expanding due to a number of factors, including rising seizure rates, an aging population, more government programs and easier access to products, rising disposable income, and increased investment...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek